| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 81,175 | 92,842 | ||
| Total stockholders' equity (deficit) | 41,865 | 53,115 | ||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | 81,175 | 92,842 | ||
Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS)